Alzheimer’s Drug Benefits Autism Kids – ScienceAlert
Summary of teh Article: Memantine and Autism – Targeting Glutamate Imbalance in the pgACC
This article discusses a clinical trial investigating the use of memantine to improve social responsiveness in children with Autism Spectrum Disorder (ASD). Here’s a breakdown of the key points:
* Focus on the pgACC: The study centers around the pregenual anterior cingulate cortex (pgACC),a brain region involved in social processing and emotional awareness. Research suggests glutamate imbalances in this area may contribute to social and interaction difficulties in individuals with ASD.
* Previous Trial & New Approach: A prior clinical trial (2017) showed memantine wasn’t generally effective. This new trial aimed to address that by:
* Higher Doses: Using a higher dosage of memantine (20mg daily).
* Specific Subset: Focusing on children without intellectual disability, aged 8-17 (predominantly male).
* key Finding: Glutamate Levels Matter: The most meaningful result was that memantine was effective only in children who had abnormally high glutamate levels in their pgACC. Caregivers reported significant improvements in communication, interaction, and engagement in this subgroup compared to those receiving a placebo.
* Cautious Optimism: The researchers emphasize the need for larger clinical trials to confirm these findings.
In essence, the study suggests that memantine could be a beneficial treatment for some children with ASD, but its effectiveness is highly likely dependent on identifying those with specific glutamate imbalances in the pgACC.